Tsang-Lin Hwang

Title: Tsang-Lin Hwang: Innovator in Biopharmaceuticals

Introduction

Tsang-Lin Hwang is a notable inventor based in Camarillo, CA (US). He has made significant contributions to the field of biopharmaceuticals through his innovative techniques in protein analysis. His work focuses on enhancing the understanding and development of therapeutic proteins.

Latest Patents

Hwang holds a patent for "Methods of fingerprinting therapeutic proteins via a two-dimensional (2D) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products." This patent discloses methods for fingerprinting specific molecules in a composition using nuclear magnetic resonance (NMR). The NMR methods he developed provide several modifications and improvements over existing techniques. In some embodiments, the methods include applying a cycle of signal processing steps, which consist of applying a radio frequency (RF) pulse, a gradient pulse with a pulse length of less than or equal to 1000 μs, and a water suppression technique (WET). Additionally, the methods involve repeating the cycle at least three times to acquire an enhanced signal of the composition, which is then used for fingerprinting the specific molecule.

Career Highlights

Hwang is currently associated with Amgen Inc., a leading biopharmaceutical company. His work at Amgen has allowed him to contribute to advancements in therapeutic protein development and analysis. His innovative approaches have the potential to improve the efficacy and safety of biopharmaceutical products.

Collaborations

Hwang has collaborated with Mats H Wikstroem, further enhancing the research and development efforts in the biopharmaceutical sector.

Conclusion

Tsang-Lin Hwang's contributions to the field of biopharmaceuticals through his innovative patent demonstrate his commitment to advancing therapeutic protein analysis. His work continues to influence the development of safer and more effective biopharmaceutical products.